CacheBy
Norgen COVID-19/Influenza (A & B) TaqMan RT-PCR Kit
AI 생성AI가 생성·보정한 이미지예요. AI는 실수할 수 있으니 실제 제품과 다를 수 있어요.
1 / 2

Norgen COVID-19/Influenza (A & B) TaqMan RT-PCR Kit

상품 한눈에 보기

SARS-CoV-2, Influenza A 및 B를 단일 반응에서 검출하는 멀티플렉스 TaqMan RT-PCR 키트. 인체 RNase P 내부대조 포함으로 샘플 품질 검증 가능. 주요 PCR 장비와 호환되며 ISO 13485 인증. -20°C 보관 시 6개월 안정성 유지.

브랜드
Norgen
카테고리
RT PCR Kits
판매단위
pk
카탈로그 보기

카탈로그

1개 옵션
회원가입 없이 바로 구매하세요
가입하지 않아도 비회원가로 구매하실 수 있습니다.
Norgen COVID-19/Influenza (A & B) TaqMan RT-PCR Kit판매 단위 pk ·
재고 확인 필요
4,727,000원VAT 포함 5,199,700원

Norgen · Norgen COVID-19/Influenza (A & B) TaqMan RT-PCR Kit

Norgen COVID-19/Influenza (A & B) TaqMan RT-PCR Detection Kit

SKU: TM67400


Features and Benefits

  • Multiplex RT-PCR system detects SARS-CoV-2 (N gene), Influenza A (M gene), and Influenza B (HA gene) in a single one-step RT-PCR reaction
  • Primer & Probe Mixes include N, M, HA, and human RP assays
  • Positive Control includes SARS-CoV-2 N gene, Influenza A M gene, Influenza B HA gene, and human RP internal control
  • Ready-to-use 2X One-Step RT-PCR Master Mix included
  • Manufactured under ISO 13485:2016 for research use only
  • CE-IVD marked version pending

View High Resolution Data


Kit Description

The kit includes 2X One-Step RT-PCR Master Mix, primer/probe mix, positive control, and negative control (nuclease-free water).
Primer/probe mix targets:

  • SARS-CoV-2 (N gene)
  • Influenza A (M gene)
  • Influenza B (HA gene)
  • Human RNase P transcript (internal control)

The positive control contains in vitro RNA transcripts for N, M, HA, and RP genes.


Compatible PCR Instruments

  • Qiagen Rotor-Gene Q
  • BioRad CFX96 Touch™ Real-Time PCR Detection System
  • ABI 7500
  • ABI QuantStudio 5 and 7

Supporting Data

Limit of Detection

PCR amplification of nasopharyngeal, oropharyngeal, and saliva samples spiked with SARS-CoV-2, Influenza A, and Influenza B viral particles at 8X, 80X, 800X, and 8,000X LoD.
Detection possible across all sample types with similar Ct values.

OCR Extracted Data (Figure 1):

A. Nasopharyngeal Swabs
| Virus | LoD Level | Ct Value |
|--------|------------|----------|
| Influenza A | 8,000X / 80X / 8X | (Ct bars) |
| Influenza B | 8,000X / 80X / 8X | (Ct bars) |
| SARS-CoV-2 | 8,000X / 80X / 8X | (Ct bars) |

B. Oropharyngeal Swabs
| Virus | LoD Level | Ct Value |
|--------|------------|----------|
| Influenza A | 8,000X / 80X / 8X | (Ct bars) |
| Influenza B | 8,000X / 80X / 8X | (Ct bars) |
| SARS-CoV-2 | 8,000X / 80X / 8X | (Ct bars) |

C. Saliva Samples
| Virus | LoD Level | Ct Value |
|--------|------------|----------|
| Influenza A | 8,000X / 80X / 8X | (Ct bars) |
| Influenza B | 8,000X / 80X / 8X | (Ct bars) |
| SARS-CoV-2 | 8,000X / 80X / 8X | (Ct bars) |

Legend:
■ Influenza A ■ Influenza B ■ SARS-CoV-2


Robustness

Ct values from nasopharyngeal and saliva samples spiked with viral particles at 3X LoD.
Interfering substances did not affect Ct values.

OCR Extracted Data (Figure 2):

A. Nasopharyngeal Swabs
| Condition | Influenza A | Influenza B | SARS-CoV-2 |
|------------|--------------|--------------|-------------|
| ddH₂O | (Ct bar) | (Ct bar) | (Ct bar) |
| RNeasy | (Ct bar) | (Ct bar) | (Ct bar) |
| MagMAX | (Ct bar) | (Ct bar) | (Ct bar) |
| QIAamp | (Ct bar) | (Ct bar) | (Ct bar) |
| Chemagen | (Ct bar) | (Ct bar) | (Ct bar) |
| PureLink | (Ct bar) | (Ct bar) | (Ct bar) |
| Promega | (Ct bar) | (Ct bar) | (Ct bar) |
| Norgen | (Ct bar) | (Ct bar) | (Ct bar) |

B. Saliva Samples
| Condition | Influenza A | Influenza B | SARS-CoV-2 |
|------------|--------------|--------------|-------------|
| ddH₂O | (Ct bar) | (Ct bar) | (Ct bar) |
| Blood | (Ct bar) | (Ct bar) | (Ct bar) |
| Mucus | (Ct bar) | (Ct bar) | (Ct bar) |
| Chloraseptic | (Ct bar) | (Ct bar) | (Ct bar) |
| Toothpaste | (Ct bar) | (Ct bar) | (Ct bar) |
| Mouthwash | (Ct bar) | (Ct bar) | (Ct bar) |
| Cepacol | (Ct bar) | (Ct bar) | (Ct bar) |
| Ricola/Halls | (Ct bar) | (Ct bar) | (Ct bar) |

Legend:
Influenza A (dark blue), Influenza B (medium blue), SARS-CoV-2 (light blue)


Freeze/Thaw Stability

Stable detection after up to 4 freeze/thaw cycles at 2X and 5X LoD.

OCR Extracted Data (Figure 3):

Condition Cycle1 Cycle2 Cycle3 Cycle4
InfA 2X LoD (Ct bar) (Ct bar) (Ct bar) (Ct bar)
InfA 5X LoD (Ct bar) (Ct bar) (Ct bar) (Ct bar)
InfB 2X LoD (Ct bar) (Ct bar) (Ct bar) (Ct bar)
InfB 5X LoD (Ct bar) (Ct bar) (Ct bar) (Ct bar)
SC2 2X LoD (Ct bar) (Ct bar) (Ct bar) (Ct bar)
SC2 5X LoD (Ct bar) (Ct bar) (Ct bar) (Ct bar)

Legend: Cycle1–Cycle4
No significant change in Ct values across cycles.


Storage Conditions and Product Stability

All components should be stored at -20°C upon arrival.
Avoid repeated thawing/freezing (>2x).
For intermittent use, freeze reagents in aliquots.
Stable for 6 months at -20°C without performance loss.


Kit Components

Component Volume / Quantity
N/Inf A & B/RP Primer & Probe Mix 850 μL
N/Inf A & B/RP Positive Control † 500 μL
2X One-Step RT-PCR Master Mix 9 × 1 mL
Nuclease-Free Water (Negative Control) 2 × 1.25 mL
Product Insert 1

† Contains in vitro RNA transcripts for SARS-CoV-2 N gene, Influenza M and HA genes, and RNase P RNA fragments.


Documentation



제품 이미지

Limit of Detection
Robustness
Freeze/Thaw Stability

Norgen 상품 둘러보기

전체보기

문의

0

아직 등록된 문의가 없어요.